In the era of precision medicine, genetic test results have become increasingly relevant in
the care of patients with Parkinson's disease (PD) and their families. While large PD …

Rapidly advancing sequencing technologies offer new and cost-effective approaches to
identify patients with hereditary neurological diseases. While studying small numbers of …

Introduction There have been no specific guidelines regarding which genes should be
tested in the clinical setting for Parkinson's disease (PD) or parkinsonism. We evaluated the …

Human genetics research lacks diversity; over 80% of genome-wide association studies
(GWAS) have been conducted on individuals of European ancestry. In addition to limiting …

Purpose To evaluate the feasibility and impact of offering genetic testing and counseling to
patients with Parkinson's disease (PD), with the potential to enroll in gene-targeted clinical …

Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, currently
affecting~ 7 million people worldwide. PD is clinically and genetically heterogeneous, with at …

Abstract Purpose of Review Parkinson's disease (PD), the second most common
neurodegenerative disease, has a worldwide prevalence projected at 12 million by 2040 …

Abstract Purpose of Review To describe current practices and attitudes about genetic testing
for Parkinson's disease (PD) among neurologists, highlight the changing scene of genetic …

Background and Objectives The PD GENEration (PD GENE) study (NCT04057794) is an
interventional clinical trial offering genetic testing with result disclosure and genetic …

Parkinson's disease (PD) is a neurodegenerative movement disorder that currently has no
disease-modifying treatment, partly owing to inefficiencies in drug target identification and …